Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28.47	40.24	53.5	102.53	160.92	25.44
Short-Term Investments	113.9	145.19	23.47	-	-	-
Cash & Short-Term Investments	142.37	185.43	76.97	102.53	160.92	25.44
Cash Growth	205.79%	140.91%	-24.93%	-36.29%	532.51%	1259.08%
Accounts Receivable	-	-	1.03	0.53	0.47	-
Other Receivables	1.03	1.05	0.82	-	-	-
Receivables	1.03	1.05	1.86	0.53	0.47	-
Prepaid Expenses	5.67	2.16	0.99	1.62	0.9	0.67
Total Current Assets	149.07	188.63	79.82	104.68	162.29	26.11
Property, Plant & Equipment	19.83	20.43	24.64	27.62	4.08	2.39
Long-Term Deferred Charges	-	-	-	-	3.17	0.59
Other Long-Term Assets	0.5	0.53	0.65	0.76	0.39	0.14
Total Assets	169.39	209.58	105.11	133.05	169.93	29.23
Accounts Payable	1.22	1.12	0.61	1.1	1.44	2.15
Accrued Expenses	5.84	7.39	8.02	10.15	10.13	3.16
Current Portion of Leases	3.64	3.74	3.6	3.49	0.43	0.46
Current Unearned Revenue	-	-	-	10.89	7.3	-
Total Current Liabilities	10.77	12.25	12.23	25.63	19.31	5.76
Long-Term Leases	9.58	10.61	13.32	15.96	1.31	1.66
Long-Term Unearned Revenue	-	-	-	15.64	21.68	-
Other Long-Term Liabilities	-	0.07	25.17	0.12	0.08	5.31
Total Liabilities	20.35	22.94	50.72	57.34	42.37	12.73
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	437.29	433.45	18.99	11.9	4.95	0.41
Retained Earnings	-288.25	-246.68	-181.31	-152.59	-93.8	-21.98
Comprehensive Income & Other	0	-0.13	0.31	-	-	-
Total Common Equity	149.04	186.64	-162.02	-140.7	-88.86	-21.57
Shareholders' Equity	149.04	186.64	54.4	75.72	127.56	16.5
Total Liabilities & Equity	169.39	209.58	105.11	133.05	169.93	29.23
Total Debt	13.22	14.35	16.91	19.45	1.74	2.12
Net Cash (Debt)	129.14	171.07	60.06	83.08	159.18	23.33
Net Cash Growth	319.41%	184.84%	-27.71%	-47.81%	582.42%	-
Net Cash Per Share	5.61	15.19	74.82	108.36	232.10	36.94
Filing Date Shares Outstanding	24.43	24.36	0.81	0.77	0.71	0.73
Total Common Shares Outstanding	24.39	24.29	0.81	0.77	0.71	0.73
Working Capital	138.3	176.38	67.59	79.05	142.98	20.34
Book Value Per Share	6.11	7.68	-200.07	-183.50	-124.96	-29.71
Tangible Book Value	149.04	186.64	-162.02	-140.7	-88.86	-21.57
Tangible Book Value Per Share	6.11	7.68	-200.07	-183.50	-124.96	-29.71
Machinery	13.29	11.88	11.24	-	2.78	0.53
Leasehold Improvements	0.75	0.41	0.39	-	0.04	0.04

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q